G1 Therapeutics, Inc. Common Stock
GTHX
GTHX was delisted on the 17th of September, 2024.
42 hedge funds and large institutions have $289M invested in G1 Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 3 closing their positions.
500% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 3
250% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 4
66% more capital invested
Capital invested by funds: $174M → $289M (+$115M)
56% more funds holding
Funds holding: 27 → 42 (+15)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$14.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.5M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.71M |
| 4 |
BlackRock
New York
|
+$6.25M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.89M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.33M |
| 3 |
Goldman Sachs
New York
|
-$1.06M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$787K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$14.2K |
GTHX Hedge Fund Activity: Q3 2017 in Review
42 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q3 2017, worth a combined $289M — up 66% from $174M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new GTHX positions and 3 closed out — a net gain of 15 holders — while 14 added to existing stakes and 4 trimmed.
The largest buyer was Franklin Resources, adding an estimated $14.5M. The largest seller was Millennium Management, exiting entirely with an estimated $1.89M sold.
- 42 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q3 2017, up from 27 in Q2 2017.
- Funds reported $289M of G1 Therapeutics, Inc. Common Stock stock for Q3 2017, up 66% quarter-over-quarter.
- 18 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q3 2017 and 3 closed out, a net change of +15 holders.
- The largest G1 Therapeutics, Inc. Common Stock buyer in Q3 2017 was Franklin Resources, an estimated $14.5M added.
- The largest G1 Therapeutics, Inc. Common Stock seller in Q3 2017 was Millennium Management, an estimated $1.89M sold.
Based on aggregated 13F filings for Q3 2017.